Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Is clarinex off patent?Drugpatentwatch trametinib?Guselkumab loss of exclusitivy?When is tenofovir alafenamide patent expiring?
See the DrugPatentWatch profile for gemtesa
Gemtesa is a prescription medication (vibegron) used to treat symptoms of overactive bladder in adults. It helps reduce urinary urgency, frequency, and urge incontinence by relaxing the bladder muscle. The usual dose is 75 mg once daily, taken with or without food, but follow your doctor’s instructions. If you have questions about whether it’s right for you, or potential interactions or side effects, talk to your healthcare provider.
Other Questions About Gemtesa :